Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Monneaux F et al. - The aim of this review article is to highlight emerging pharmacological options and new therapeutic avenues for lupus with a focus on non-antibody molecular strategies, particularly fusion proteins, peptides and small molecules that represent excellent alternative tools for immune intervention.

Novel targets in the treatment of lupus patients- ongoing therapeutic trials:

  • Cell surface-expressed molecules
  • Compounds targeting intracellular components
  • Agents that modulate the hormonal pathway
  • Modulation of sex steroid hormones
  • Inhibition of prolactin
  • Autoantigens

    Although the current literature search shows a number of promising molecules that are impressively efficient in murine models of lupus, very few of these molecules reach the standard required for evaluating them in clinical trials. Managing patients with SLE is challenging and new treatments are eagerly awaited.


    Sponsor
  • Article Search

    Keyword:

    Search:

    Published within

    Sort By:
    Date
    Relevance


    Sponsor

    Sponsor

    Send this Summary to a Colleague

    Enter email address